As we age, our bodies face numerous challenges, including a decline in immune system function and an increased vulnerability to various health issues.
A study has recently shed light on these challenges and unveiled a potential solution that could have far-reaching implications for ageing individuals.
The ageing process is often accompanied by a decline in the proper functioning of the haematopoietic and immune systems, making older adults more susceptible to infections, blood disorders, and even tumour development.
The study published on August 31st, 2023 in the journal Nature Ageing, led by Nicola Vannini, group leader in the Department of oncology UNIL-CHUV in Lausanne (CH) and member of the Lausanne branch of the Ludwig Institute for Cancer Research, focused on a key player in the blood system – haematopoietic stem cells (HSCs).
These cells are responsible for generating various types of blood cells, playing a critical role in maintaining a healthy immune system.
As we age, HSCs experience a decline in their ability to regenerate blood and show a preference for a specific type of cell lineage, which contributes to immune system dysfunction.
However, the researchers discovered a remarkable solution.
By introducing a naturel compound called urolithin A, which targets mitochondria – the energy powerhouses of cells – they were able to reverse the decline in HSC function.
Mitochondria abnormalities were identified as a contributing factor to the ageing of HSCs.
Urolithin A acted as a mitochondrial modulator, effectively restoring the mitochondrial function within HSCs.
Urolithins are not found in food; however, their precursors are.
Urolithin A is the result of transformation of ellagic acids and ellagitannins by the gut microflora in humans.
Ellagitannins are found in pomegranates, nuts, some berries.
The most interesting finding of this preclinical study was that this intervention not only rejuvenated the blood reconstitution capability of older HSCs but also improved immune system function in aged mice.
When urolithin A was incorporated as a dietary supplement, it not only revitalised the immune system's lymphoid compartments but also enhanced overall HSC performance.
This translated to an improved immune response against viral infections, showcasing the potential of urolithin A to combat age-related immune system decline.
In essence, this research indicates that by encouraging the recycling of mitochondria using urolithin A, it is possible to reverse the ageing process within the haematopoietic and immune systems.
These findings hold promise for the development of interventions targeted at addressing age-related health conditions in older individuals and pave the way for envisioning clinical trials.
Source: University of Lausanne
We are an independent charity and are not backed by a large company or society. We raise every penny ourselves to improve the standards of cancer care through education. You can help us continue our work to address inequalities in cancer care by making a donation.
Any donation, however small, contributes directly towards the costs of creating and sharing free oncology education.
Together we can get better outcomes for patients by tackling global inequalities in access to the results of cancer research.
Thank you for your support.